UBS Group AG lessened its holdings in Transcat, Inc. (NASDAQ:TRNS – Free Report) by 18.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 36,308 shares of the scientific and technical instruments company’s stock after selling 8,480 shares during the quarter. UBS Group AG owned 0.39% of Transcat worth $2,060,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Transcat by 6.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock valued at $407,000 after buying an additional 325 shares during the period. Linden Thomas Advisory Services LLC increased its holdings in Transcat by 4.4% in the 3rd quarter. Linden Thomas Advisory Services LLC now owns 10,840 shares of the scientific and technical instruments company’s stock valued at $793,000 after buying an additional 453 shares during the period. PNC Financial Services Group Inc. increased its holdings in Transcat by 42.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 1,530 shares of the scientific and technical instruments company’s stock valued at $112,000 after buying an additional 458 shares during the period. Verition Fund Management LLC increased its holdings in Transcat by 6.4% in the 3rd quarter. Verition Fund Management LLC now owns 8,982 shares of the scientific and technical instruments company’s stock valued at $657,000 after buying an additional 539 shares during the period. Finally, Legal & General Group Plc increased its holdings in Transcat by 6.1% in the 2nd quarter. Legal & General Group Plc now owns 9,551 shares of the scientific and technical instruments company’s stock valued at $821,000 after buying an additional 548 shares during the period. Institutional investors own 98.34% of the company’s stock.
Transcat Stock Down 1.7%
Shares of NASDAQ:TRNS opened at $78.96 on Friday. Transcat, Inc. has a 52 week low of $50.23 and a 52 week high of $91.45. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.85 and a current ratio of 2.21. The company’s fifty day moving average is $75.99 and its 200-day moving average is $68.28. The company has a market capitalization of $736.70 million, a PE ratio of 136.14 and a beta of 0.68.
Analyst Ratings Changes
Several equities research analysts have issued reports on TRNS shares. Zacks Research raised shares of Transcat from a “strong sell” rating to a “hold” rating in a report on Friday, May 15th. Weiss Ratings reissued a “sell (d)” rating on shares of Transcat in a report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Transcat has an average rating of “Moderate Buy” and an average price target of $105.33.
View Our Latest Report on TRNS
About Transcat
Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.
In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.
Featured Stories
- Five stocks we like better than Transcat
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
